TrialAntimicrobial agents and chemotherapy2022

Safety, Tolerability, and Pharmacokinetics of Telacebec (Q203), a New Antituberculosis Agent, in Healthy Subjects.

Jeongjun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.